ELF3 links kidney function GWAS loci to maladaptive epithelial inflammation
Science Advances · 24.07.2026 · 12 (30)
DOI: 10.1126/sciadv.aec6741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.07.2026. Verfasst von Yanjuan Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 1910…. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Proto-Oncogene Proteins c-ets, Transcription Factors, Inflammation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Genome-wide association studies (GWAS) have uncovered over a thousand loci associated with kidney function, but the effector genes and mechanisms remain largely unknown. Here, we demonstrate that ELF3 is the effector gene at a kidney function GWAS locus and acts as an epithelial proinflammatory amplifier of the reprogramming of injured proximal tubules (iPTs). E74-like factor 3 (ELF3) expression is induced in iPTs in both mouse models and human chronic kidney disease (CKD), where it defines transitional epithelial states enriched for inflammatory gene programs and surrounded by leukocyte infiltrates. Conditional deletion of Elf3 in mice after injury reduced iPT accumulation, cytokine production, and immune cell recruitment. Mechanistically, ELF3 directly bound and activated components of the noncanonical nuclear factor κB (NF-κB) pathway ( Nf κ b2 , Map3k14 , and Il6r ) and was required for NFκB2 nuclear translocation and cytokine induction. Spatial transcriptomics and immunofluorescence of human CKD kidneys confirmed that ELF3 expression correlates with epithelial inflammation, disease progression, and loss of kidney function. Together, these findings establish ELF3 as a genetically validated effector gene that drives inflammatory reprogramming in iPTs, nominating it as a therapeutic target to blunt maladaptive inflammation in CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
- Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
- Penn/CHOP Kidney Innovation Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
ORCID-Profile: Yanjuan Hou, Konstantin Kloetzer, Eunji Ha, Hongbo Liu, Dhanunjay Mukhi, Magaiver Andrade-Silva, Siyu Pan, Katalin Susztak
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Hou, Y., Kloetzer, K., Dumoulin, B., Ha, E., Liu, H., Mukhi, D., Andrade-Silva, M., Hu, X., Pan, S., & Susztak, K. (2026). ELF3 links kidney function GWAS loci to maladaptive epithelial inflammation. Science Advances, 12(30). https://doi.org/10.1126/sciadv.aec6741
Vancouver
Hou Y, Kloetzer K, Dumoulin B, Ha E, Liu H, Mukhi D, et al. ELF3 links kidney function GWAS loci to maladaptive epithelial inflammation. Science Advances. 2026;12(30). doi:10.1126/sciadv.aec6741
BibTeX
@article{Hou2026,
author = {Hou, Yanjuan and Kloetzer, Konstantin and Dumoulin, Bernhard and Ha, Eunji and Liu, Hongbo and Mukhi, Dhanunjay and Andrade-Silva, Magaiver and Hu, Xuemei and Pan, Siyu and Susztak, Katalin},
title = {ELF3 links kidney function GWAS loci to maladaptive epithelial inflammation},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {30},
doi = {10.1126/sciadv.aec6741}
}
EUVIMED